Additional file 10: Figure S9. of EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
Year: 2017
Type: article
Abstract: Clinical relevance of SPOCK1 in different breast cancer subtypes. A. Relapse-free survival analysis of all patients included in the GSE2034 cohort (n = 286), classified into “high SPOCK1” and “low SPOCK1” based on median expression value of SPOCK1. B. SPOCK1 mRNA expression levels in the primary tumors, classified by molecular subtypes. Whiskers represent minimum and maximum values. AU, arbitrary units. C. Relapse-free survival curves for each molecular subtype of breast cancer. Log-rank test was used to determine p values in all cases. ns, non-statistical significance. (PPTX 288 kb)
Source: Figshare
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7161401649
